Clinical Trial Update: Pioglitazone and Losartan Provides Additional Renoprotection [NA]

View source ↗

Summary

A completed clinical trial evaluating pioglitazone plus losartan suggests additional renoprotective effects in patients with type 2 diabetes mellitus and diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Losartan (losartan)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Type 2 Diabetes, Diabetic Nephropathy | NA | Status: COMPLETED